drugset / Trial / NCT01105936

Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)

NCT01105936 ↗

Phase 4 Completed 31 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindBasic science

Summary

Blood-Oxygen-Level-Dependent (BOLD) responses to painful mechanical stimulation of the OA knee following treatment with four consecutive doses (at 8 hour intervals) on giving sustained released paracetamol treatment or placebo will be compared. The fMRI and pain assessments will occur approximately 2-5 hours after taking the final dose.

Timeline

Start
2010-09-01
Primary completion
2011-08-01
Completion
2011-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 665 mg Oral

Indications